Laura Lawrence
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
- Pharmacology 29
- Antibiotics Pharmacokinetics and Efficacy 27
-
- Antimicrobial Resistance in Staphylococcus 24
- Co-authors
- Sue Cammarata (28 shared papers)John F. Barrett (10 shared papers)Randall Hoover (8 shared papers)Eugene Sun (7 shared papers)Susan K. Paulson (7 shared papers)Miri Seiberg (2 shared papers)Purvi Mehra (2 shared papers)John Pullman (5 shared papers)
- Journals
- Open Forum Infectious Diseases (14 papers)Antimicrobial Agents and Chemotherapy (10 papers)Expert Opinion on Investigational Drugs (5 papers)The Journal of Clinical Pharmacology (4 papers)Clinical Therapeutics (3 papers)
- Partner nations
- United StatesRomaniaUnited Kingdom
In The Last Decade
Laura Lawrence
51 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Molecular Medicine 378
- Clinical Biochemistry 230
- Applied Microbiology and Biotechnology 66
- Pharmacology 513
- Infectious Diseases 541
Countries citing papers authored by Laura Lawrence
This map shows the geographic impact of Laura Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Lawrence more than expected).
Fields of papers citing papers by Laura Lawrence
This network shows the impact of papers produced by Laura Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Lawrence. The network helps show where Laura Lawrence may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 99 | |
| 2 | 2014 | 86 | |
| 3 | 2017 | 83 | |
| 4 | 2017 | 67 | |
| 5 | 2015 | 66 | |
| 6 | 2008 | 61 | |
| 7 | 2008 | 55 | |
| 8 | 2015 | 45 | |
| 9 | 1997 | 45 | |
| 10 | 2015 | 44 | |
| 11 | 2015 | 44 | |
| 12 | 2019 | 38 | |
| 13 | 1992 | 34 | |
| 14 | 2016 | 30 | |
| 15 | Apoptosis in Pam212, an epidermal keratinocyte cell line: a possible role for bcl-2 in epidermal differentiation. | 1995 | 30 |
| 16 | 2019 | 29 | |
| 17 | 2017 | 28 | |
| 18 | 2018 | 27 | |
| 19 | 2017 | 24 | |
| 20 | 2018 | 21 |
About Laura Lawrence
Laura Lawrence is a scholar working on Pharmacology, Infectious Diseases, Molecular Medicine, Epidemiology and Molecular Biology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (27 papers), Antimicrobial Resistance in Staphylococcus (24 papers), Antibiotic Resistance in Bacteria (17 papers), Bacterial Identification and Susceptibility Testing (13 papers), Pneumonia and Respiratory Infections (13 papers), Streptococcal Infections and Treatments (7 papers), Cancer therapeutics and mechanisms (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Molecular Medicine (378 citations), Clinical Biochemistry (230 citations), Applied Microbiology and Biotechnology (66 citations), Pharmacology (513 citations) and Infectious Diseases (541 citations). Laura Lawrence has collaborated with scholars based in United States, Romania and United Kingdom. Frequent co-authors include Sue Cammarata, John F. Barrett, Randall Hoover, Eugene Sun, Susan K. Paulson, Miri Seiberg, Purvi Mehra, John Pullman, Kurt S. Stenn and Stanley J. Korsmeyer. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Expert Opinion on Investigational Drugs, The Journal of Clinical Pharmacology and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.